Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University, School of Medicine, 638 Robinson Research Building, 2200 Pierce Avenue, Nashville, TN 37232-0146, USA.
Chem Res Toxicol. 2012 Aug 20;25(8):1740-51. doi: 10.1021/tx3001994. Epub 2012 Jul 10.
Both 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203) and 5-fluoro-2-(3,4-dimethoxyphenyl)-benzothiazole (GW 610) contain the benzothiazole pharmacophore and possess potent and selective in vitro antitumor properties. Prior studies suggested the involvement of cytochrome P450 (P450) 1A1 and 2W1-mediated bioactivation in the antitumor activities and P450 2S1-mediated deactivation of 5F 203 and GW 610. In the present study, the biotransformation pathways of 5F 203 and GW 610 by P450s 1A1, 2W1, and 2S1 were investigated, and the catalytic parameters of P450 1A1- and 2W1-catalyzed oxidation were determined in steady-state kinetic studies. The oxidations of 5F 203 catalyzed by P450s 1A1 and 2W1 yielded different products, and the formation of a hydroxylamine was observed for the first time in the latter process. Liquid chromatography-mass spectrometry (LC-MS) analysis with the synthetic hydroxylamine and also a P450 2W1/5F 203 incubation mixture indicated the formation of dGuo adduct via a putative nitrenium intermediate. P450 2W1-catalyzed oxidation of GW 610 was 5-fold more efficient than the P450 1A1-catalyzed reaction. GW 610 underwent a two-step oxidation process catalyzed by P450 1A1 or 2W1: a regiospecific O-demethylation and a further hydroxylation. Glutathione (GSH) conjugates of 5F 203 and GW 610, presumably through a quninoneimine and a 1,2-quinone intermediate, respectively, were detected. These results demonstrate that human P450s 1A1 and 2W1 mediate 5F 203 and GW 610 bioactivation to reactive intermediates and lead to GSH conjugates and a dGuo adduct, which may account for the antitumor activities of 5F 203 and GW 610 and also be involved in cell toxicity. P450 2S1 can catalyze the reduction of the hydroxylamine to the amine 5F 203 under anaerobic conditions and, to a lesser extent, under aerobic conditions, thus attenuating the anticancer activity.
2-(4-氨基-3-甲基苯基)-5-氟苯并噻唑(5F203)和 5-氟-2-(3,4-二甲氧基苯基)-苯并噻唑(GW610)均含有苯并噻唑药效团,具有强大且选择性的体外抗肿瘤特性。先前的研究表明,细胞色素 P450(P450)1A1 和 2W1 介导的生物活化参与了抗肿瘤活性,而 P450 2S1 介导的 5F203 和 GW610 的失活。在本研究中,研究了 P450s 1A1、2W1 和 2S1 对 5F203 和 GW610 的生物转化途径,并在稳态动力学研究中确定了 P450 1A1 和 2W1 催化氧化的催化参数。P450s 1A1 和 2W1 催化的 5F203 氧化生成了不同的产物,并且在后一种过程中首次观察到羟胺的形成。使用合成的羟胺和 P450 2W1/5F203 孵育混合物的液相色谱-质谱(LC-MS)分析表明,通过假定的氮烯中间体形成 dGuo 加合物。与 P450 1A1 催化反应相比,P450 2W1 催化的 GW610 氧化效率高 5 倍。GW610 经历了 P450 1A1 或 2W1 催化的两步氧化过程:一个区域特异性的 O-脱甲基化和进一步的羟化。通过分别通过醌亚胺和 1,2-醌中间体检测到 5F203 和 GW610 的谷胱甘肽(GSH)缀合物。这些结果表明,人 P450s 1A1 和 2W1 介导 5F203 和 GW610 的生物活化,生成反应性中间体,并导致 GSH 缀合物和 dGuo 加合物,这可能解释了 5F203 和 GW610 的抗肿瘤活性,也可能与细胞毒性有关。在厌氧条件下,P450 2S1 可以催化羟胺还原为 5F203 的胺,在有氧条件下,还原效率较低,从而减弱了抗癌活性。